In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...

Amid these staggering projections, there are still many unknowns about neurodegenerative diseases and memory loss, but within ...

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis. For years prior, she’d had severe fatigue, which a neurologist initially suspec ...

Understanding MS: Symptoms, care, and treatment advances ...

Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across ...

George Mckinty found he "couldn’t see out of one eye properly" and assumed this was causing his clumsiness ...

This administration has given the company, staffed by the president’s allies, multimillion-dollar contracts it was guaranteed ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), ...

The outbreak, believed to have affected mostly people aged 18 to 21, has prompted the UK Health Security Agency to contact ...

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...